Company Dynamic

Univar Solutions has announced that it has acquired UK-based Brad-Chem Holdings and its affiliates.

• Univar Solutions
• Brad-Chem

According to Dutch trade unions FNV and CNV, LyondellBasell's (LYB) plastic precursor production plant in Maasvirat, Port of Rotterdam, Netherlands, may face closure.

• LyondellBasell

Eight of Eastman’s copolyester resins and their equivalent Renew grades containing recycled content have received the RecyClass certification for recyclability.

• Eastman
• copolyester resin

Unilever is rumored to be close to agreeing to buy Wild for £230 million. If the deal goes through, it would be one of the most significant deals in the personal care space for the British fast-moving consumer goods manufacturer in recent years.

• Unilever
• Wild

Fujifilm Corporation announced that it will install new CMP slurry and advanced semiconductor material production facilities at its production base in Belgium and enhance existing lithography-related material facilities.

• Fujifilm
• semiconductor

Nouryon announces the opening of a new office in Al Dhahran, Saudi Arabia, located in Al Abdulkarim Tower. This move is an important milestone in Nouryon's commitment to expand its presence and better serve customers in the Middle East.

• Nouryon

On January 5, Poly Pharm announced that it is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws.

Merck KGaA (MRCG.DE), the German healthcare and technology powerhouse, announced on Monday that it is in advanced negotiations to acquire U.S. biotech firm SpringWorks Therapeutics (SWTX.O), known for its focus on cancer and rare diseases.

Mitsubishi Chemical announced a definitive agreement to sell Tanabe Pharma to Bain Capital for approximately ¥510 billion (around ¥245 billion RMB).

Japanese chemical giant Asahi Kasei announced a significant decision during its board meeting to absorb its wholly-owned subsidiary, Asahi Kasei Epoxy Corporation, through a merger.

According to a review by Cybex, AstraZeneca emerged as the clear leader with $6.41 billion in revenue, reflecting an impressive 11% growth.

Novartis has announced that its nuclear medicine product, Pluvicto (177Lu-PSMA-617), achieved $1.39 billion in sales for the year 2024, marking a 42% increase compared to the previous year.

Syensqo recently announced a five-year strategic partnership with Bota Bio, a global industrial biotech company specializing in biomanufacturing, clean and high-performance consumer products.

• Syensqo
• Bota Bio

The Board of Directors of BASF India Ltd has approved the closure of the Turbine Tube Dryer (TTD) unit at Dahej manufacturing site, which is associated with the company’s Care Chemicals business.

• BASF
• TTD
• Turbine Tube Dryer

LG Chem and Lotte Chemical both posted losses in 2024, and executives at both companies said this week that the losses were mainly dragged down by oversupply, which will continue this year, while trade turmoil dampens the global economic outlook.

• LG chem
• Lotte chemical

Pfizer disclosed a $2 billion impairment on its intangible assets, specifically related to Vadistuzumab (an anti-HER2 ADC) acquired from Rongchang Biopharma.

The global pharmaceutical landscape has dramatically shifted as 2025 approaches, marking a significant reshuffle among the top players.

Dow Inc. released its financial results for the fourth quarter of 2024, reporting $10.4 billion in net sales, a 2% decline year-over-year, primarily due to decreased performance in the packaging and specialty plastics segment.

BASF now launches Basotect EcoBalanced, the world’s first melamine foam, which helps reduce the carbon footprint of products for a variety of sound absorption applications in the transportation and construction industries.

• BASF
• Basotect EcoBalanced
• melamine foam

U.S. Department of Justice announced that Pfizer's wholly-owned subsidiary Biohaven Pharmaceutical Holding Company has agreed to pay $59.74 million (approximately 434 million RMB) to resolve allegations related to false claims.